“But that level of testing can be done in India and the MHRA (industry regulator) does sometimes go over for India for testing.
“But provided the regulatory standard are high and are regulated by the MHRA, there is no reason to duplicate that testing, and that would knock a month off (medicines getting supplied to the UK).
“Reducing red tape would knock a month off the transport time for those medicines to get to the NHS, so it (a trade deal) is really important.”
Mr Samuels argues that with this reduction in the inefficiency of the approval of manufacturing and export licensing for controlled drugs, the NHS will be able to access these medicines far quicker.
READ MORE: Musk facing nightmare as space tourists trapped on ISS after bad weather sparks NASA fears
Article source: https://www.express.co.uk/news/science/1599862/india-uk-trade-deal-nhs-red-tape-pandemic-brexit